USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS

Ming-Shi Chang

USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS

Department of Biochemistry and Molecular Biology

Research output: Patent

Abstract

The invention provides an IL-20 antagonist for use in treating, delaying the onset of, or preventing osteoporosis in an individual, as set out in the appended claims.

Translated title of the contribution	利用抗IL-20抗體治療類風濕性關節炎及骨質疏鬆症
Original language	English
Patent number	2340039
Publication status	Published - 1800

Cite this

@misc{5c0e4de28b894667b0dc6331f1136b8d,

title = "USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS",

abstract = "The invention provides an IL-20 antagonist for use in treating, delaying the onset of, or preventing osteoporosis in an individual, as set out in the appended claims.",

author = "Ming-Shi Chang",

year = "1800",

language = "English",

type = "Patent",

note = "2340039",

}

TY - PAT

T1 - USE OF IL-20 ANTAGONISTS FOR TREATING RHEUMATOID ARTHRITIS AND OSTEOPOROSIS

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - The invention provides an IL-20 antagonist for use in treating, delaying the onset of, or preventing osteoporosis in an individual, as set out in the appended claims.

AB - The invention provides an IL-20 antagonist for use in treating, delaying the onset of, or preventing osteoporosis in an individual, as set out in the appended claims.

M3 - Patent

M1 - 2340039

ER -